NCT05974410 2025-10-02Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer PatientsAVM Biotechnology IncAvailable
NCT04681248 2025-08-03Expanded Access Use of DKN-01 for the Treatment of Advanced Solid TumorsLeap Therapeutics, Inc.No longer available
NCT02784158 2018-02-06An Expanded Access Study of Brigatinib for Patients With ALK-positive Advanced Non-Small Cell Lung CancerTakedaNo longer available